CDC identifies drug-resistant superbugs threatening Americans

Key Points:

• The CDC's latest Antimicrobial Resistance Threats Report reveals that drug-resistant bacteria and fungi cause approximately 9.7 million infections and 50,800 deaths annually in the U.S., with healthcare-associated infections accounting for over 42,000 deaths and $12 billion in costs.
• Four pathogens are classified as "urgent" threats: Candida auris, carbapenem-resistant Enterobacterales (CRE), carbapenem-resistant Acinetobacter, and drug-resistant Neisseria gonorrhoeae, all posing significant challenges due to their resistance to powerful antibiotics and their prevalence in healthcare or community settings.
• The rise of drug-resistant germs is largely driven by the overuse and misuse of antibiotics, leading to mutations that render treatments ineffective and threatening modern medical procedures like chemotherapy and organ transplants.
• While some threats like C. diff have been downgraded due to successful public health efforts, other serious threats including drug-resistant salmonella, shigella, and tuberculosis remain concerning, with some spreading outside healthcare environments.
• The CDC emphasizes good hygiene practices, such as thorough handwashing, as the most effective way to prevent the spread of these infections and highlights ongoing efforts to provide high-quality data to combat antimicrobial resistance.